{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T09:45:33Z","timestamp":1782639933934,"version":"3.54.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,28]]},"DOI":"10.7759\/cureus.111643","type":"journal-article","created":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T09:19:16Z","timestamp":1782638356000},"source":"Crossref","is-referenced-by-count":0,"title":["Hemochromatosis-Associated Mortality in the United States (1999-2024): A Nationwide Joinpoint Analysis of Trends and Disparities"],"prefix":"10.7759","author":[{"given":"Zenab M","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamza B","family":"Amir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Uzair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astad Y","family":"Sidhwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(15)01315-x","article-title":"Haemochromatosis","volume":"388","author":"Powell LW","year":"2016","unstructured":"Powell LW, Seckington RC, Deugnier Y. Haemochromatosis. Lancet. 2016, 388:706-16. 10.1016\/s0140-6736(15)01315-x","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2018.16","article-title":"Haemochromatosis","volume":"4","author":"Brissot P","year":"2018","unstructured":"Brissot P, Pietrangelo A, Adams PC, de Graaff B, McLaren CE, Lor\u00e9al O. Haemochromatosis. Nat Rev Dis Primers. 2018, 4:18016. 10.1038\/nrdp.2018.16","journal-title":"Nat Rev Dis Primers"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000000315","article-title":"ACG clinical guideline: hereditary hemochromatosis","volume":"114","author":"Kowdley KV","year":"2019","unstructured":"Kowdley KV, Brown KE, Ahn J, Sundaram V. ACG clinical guideline: hereditary hemochromatosis. Am J Gastroenterol. 2019, 114:1202-18. 10.14309\/ajg.0000000000000315","journal-title":"Am J Gastroenterol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24330","article-title":"Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases","volume":"54","author":"Bacon BR","year":"2011","unstructured":"Bacon BR, Adams PC, Kowdley KV, Powell LW, Tavill AS. Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology. 2011, 54:328-43. 10.1002\/hep.24330","journal-title":"Hepatology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/ng0896-399","article-title":"A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis","volume":"13","author":"Feder JN","year":"1996","unstructured":"Feder JN, Gnirke A, Thomas W, et al.. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996, 13:399-408. 10.1038\/ng0896-399","journal-title":"Nat Genet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/154.3.193","article-title":"HFE gene and hereditary hemochromatosis: a HuGE review. Human Genome Epidemiology","volume":"154","author":"Hanson EH","year":"2001","unstructured":"Hanson EH, Imperatore G, Burke W. HFE gene and hereditary hemochromatosis: a HuGE review. Human Genome Epidemiology. Am J Epidemiol. 2001, 154:193-206. 10.1093\/aje\/154.3.193","journal-title":"Am J Epidemiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041534","article-title":"Hemochromatosis and iron-overload screening in a racially diverse population","volume":"352","author":"Adams PC","year":"2005","unstructured":"Adams PC, Reboussin DM, Barton JC, et al.. Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med. 2005, 352:1769-78. 10.1056\/NEJMoa041534","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k5222","article-title":"Common conditions associated with hereditary haemochromatosis genetic variants: cohort study in UK Biobank","volume":"364","author":"Pilling LC","year":"2019","unstructured":"Pilling LC, Tamosauskaite J, Jones G, et al.. Common conditions associated with hereditary haemochromatosis genetic variants: cohort study in UK Biobank. BMJ. 2019, 364:k5222. 10.1136\/bmj.k5222","journal-title":"BMJ"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-081926","article-title":"HFE genotypes, haemochromatosis diagnosis and clinical outcomes at age 80 years: a prospective cohort study in the UK Biobank","volume":"14","author":"Lucas MR","year":"2024","unstructured":"Lucas MR, Atkins JL, Pilling LC, Shearman JD, Melzer D. HFE genotypes, haemochromatosis diagnosis and clinical outcomes at age 80 years: a prospective cohort study in the UK Biobank. BMJ Open. 2024, 14:e081926. 10.1136\/bmjopen-2023-081926","journal-title":"BMJ Open"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.21566","article-title":"Association of hemochromatosis HFE p.C282Y homozygosity with hepatic malignancy","volume":"324","author":"Atkins JL","year":"2020","unstructured":"Atkins JL, Pilling LC, Masoli JA, Kuo CL, Shearman JD, Adams PC, Melzer D. Association of hemochromatosis HFE p.C282Y homozygosity with hepatic malignancy. JAMA. 2020, 324:2048-57. 10.1001\/jama.2020.21566","journal-title":"JAMA"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1996.v110.pm8613000","article-title":"Long-term survival in patients with hereditary hemochromatosis","volume":"110","author":"Niederau C","year":"1996","unstructured":"Niederau C, Fischer R, P\u00fcrschel A, Stremmel W, H\u00e4ussinger D, Strohmeyer G. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology. 1996, 110:1107-19. 10.1053\/gast.1996.v110.pm8613000","journal-title":"Gastroenterology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-129-11_part_2-199812011-00005","article-title":"Hemochromatosis-associated mortality in the United States from 1979 to 1992: an analysis of Multiple-Cause Mortality Data","volume":"129","author":"Yang Q","year":"1998","unstructured":"Yang Q, McDonnell SM, Khoury MJ, Cono J, Parrish RG. Hemochromatosis-associated mortality in the United States from 1979 to 1992: an analysis of Multiple-Cause Mortality Data. Ann Intern Med. 1998, 129:946-53. 10.7326\/0003-4819-129-11_part_2-199812011-00005","journal-title":"Ann Intern Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/00125817-200103000-00004","article-title":"Hemochromatosis-associated morbidity in the United States: an analysis of the National Hospital Discharge Survey, 1979-1997","volume":"3","author":"Brown AS","year":"2001","unstructured":"Brown AS, Gwinn M, Cogswell ME, Khoury MJ. Hemochromatosis-associated morbidity in the United States: an analysis of the National Hospital Discharge Survey, 1979-1997. Genet Med. 2001, 3:109-11. 10.1097\/00125817-200103000-00004","journal-title":"Genet Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/BS9.0000000000000151","article-title":"The evolution of iron-related comorbidities and hospitalization in patients with hemochromatosis: an analysis of the nationwide inpatient sample","volume":"5","author":"Abou Yassine A","year":"2023","unstructured":"Abou Yassine A, MacDougall K, Sasso R, et al.. The evolution of iron-related comorbidities and hospitalization in patients with hemochromatosis: an analysis of the nationwide inpatient sample. Blood Sci. 2023, 5:131-5. 10.1097\/BS9.0000000000000151","journal-title":"Blood Sci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/clc.70180","article-title":"Trends in sudden cardiac death related mortality in adults in the United States: a CDC WONDER database analysis, 1999-2020","volume":"48","author":"Bhagwan R","year":"2025","unstructured":"Bhagwan R, Nabi R, Rath S, et al.. Trends in sudden cardiac death related mortality in adults in the United States: a CDC WONDER database analysis, 1999-2020. Clin Cardiol. 2025, 48:e70180. 10.1002\/clc.70180","journal-title":"Clin Cardiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/frhem.2025.1560766","article-title":"Trends in hemolytic anemia-related mortality in the United States from 1999-2022","volume":"4","author":"Tuin A","year":"2025","unstructured":"Tuin A, Diehl T, Billion T, Mirza M, Tauseef A, Abdul Jabbar AB. Trends in hemolytic anemia-related mortality in the United States from 1999-2022. Front Hematol. 2025, 4:2025. 10.3389\/frhem.2025.1560766","journal-title":"Front Hematol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-026-05510-8","article-title":"Trends and disparities in amyloidosis and cardiovascular disease mortality: a population-based retrospective study in the United States (1999-2020)","volume":"26","author":"Ahmed F","year":"2026","unstructured":"Ahmed F, Mirza TR, Iftikhar Z, et al.. Trends and disparities in amyloidosis and cardiovascular disease mortality: a population-based retrospective study in the United States (1999-2020). BMC Cardiovasc Disord. 2026, 26:10.1186\/s12872-026-05510-8","journal-title":"BMC Cardiovasc Disord"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahjo.2025.100499","article-title":"Underlying and contributing causes of mortality from CDC WONDER-Insights for researchers","volume":"50","author":"Minhas AM","year":"2025","unstructured":"Minhas AM, Sperling LS, Al-Kindi S, Abramov D. Underlying and contributing causes of mortality from CDC WONDER-Insights for researchers. Am Heart J Plus. 2025, 50:100499. 10.1016\/j.ahjo.2025.100499","journal-title":"Am Heart J Plus"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-0258(20000215)19:3%3C335::aid-sim336%3E3.0.co;2-z","article-title":"Permutation tests for joinpoint regression with applications to cancer rates","volume":"19","author":"Kim HJ","year":"2000","unstructured":"Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000, 19:335-51. 10.1002\/(sici)1097-0258(20000215)19:3%3C335::aid-sim336%3E3.0.co;2-z","journal-title":"Stat Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm E","year":"2008","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008, 61:344-9. 10.1016\/j.jclinepi.2007.11.008","journal-title":"J Clin Epidemiol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001885","article-title":"The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement","volume":"12","author":"Benchimol EI","year":"2015","unstructured":"Benchimol EI, Smeeth L, Guttmann A, et al.. The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement. PLoS Med. 2015, 12:e1001885. 10.1371\/journal.pmed.1001885","journal-title":"PLoS Med"},{"key":"ref22","unstructured":"Centers for Disease Control and Prevention, National Center for Health Statistics. Multiple Cause of Death on CDC WONDER Online Database. (2024). Accessed: April 20, 2026: https:\/\/wonder.cdc.gov\/mcd.html."},{"key":"ref23","article-title":"Age standardization of death rates: implementation of the year 2000 standard","volume":"47","author":"Anderson RN","year":"1998","unstructured":"Anderson RN, Rosenberg HM. Age standardization of death rates: implementation of the year 2000 standard. Natl Vital Stat Rep. 1998, 47:1-16.","journal-title":"Natl Vital Stat Rep"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.14218\/JCTH.2023.00356","article-title":"Hepatocellular carcinoma incidence and mortality in the USA by sex, age, and race: a nationwide analysis of two decades","volume":"12","author":"Abboud Y","year":"2024","unstructured":"Abboud Y, Ismail M, Khan H, Medina-Morales E, Alsakarneh S, Jaber F, Pyrsopoulos NT. Hepatocellular carcinoma incidence and mortality in the USA by sex, age, and race: a nationwide analysis of two decades. J Clin Transl Hepatol. 2024, 12:172-81. 10.14218\/JCTH.2023.00356","journal-title":"J Clin Transl Hepatol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0004705","article-title":"Disparities in chronic ischemic heart disease-related mortality across sex, race, and urbanization status in the United States, 1999-2019","volume":"5","author":"Kwaah PA","year":"2025","unstructured":"Kwaah PA, Mensah SA, Carboo A, et al.. Disparities in chronic ischemic heart disease-related mortality across sex, race, and urbanization status in the United States, 1999-2019. PLOS Glob Public Health. 2025, 5:e0004705. 10.1371\/journal.pgph.0004705","journal-title":"PLOS Glob Public Health"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.athplu.2025.09.004","article-title":"Demographic and regional trends of mortality in patients with cardiovascular disease and liver cirrhosis in the United States between 1999 and 2019","volume":"62","author":"Yasmin F","year":"2025","unstructured":"Yasmin F, Moeed A, Fahim MA, Kumar G, Shaharyar M, Asghar MS. Demographic and regional trends of mortality in patients with cardiovascular disease and liver cirrhosis in the United States between 1999 and 2019. Atheroscler Plus. 2025, 62:1-8. 10.1016\/j.athplu.2025.09.004","journal-title":"Atheroscler Plus"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2017.121","article-title":"Clinical penetrance in hereditary hemochromatosis: estimates of the cumulative incidence of severe liver disease among HFE C282Y homozygotes","volume":"20","author":"Grosse SD","year":"2018","unstructured":"Grosse SD, Gurrin LC, Bertalli NA, Allen KJ. Clinical penetrance in hereditary hemochromatosis: estimates of the cumulative incidence of severe liver disease among HFE C282Y homozygotes. Genet Med. 2018, 20:383-9. 10.1038\/gim.2017.121","journal-title":"Genet Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2014.12.001","article-title":"Hepcidin-induced hypoferremia is a critical host defense mechanism against the siderophilic bacterium Vibrio vulnificus","volume":"17","author":"Arezes J","year":"2015","unstructured":"Arezes J, Jung G, Gabayan V, et al.. Hepcidin-induced hypoferremia is a critical host defense mechanism against the siderophilic bacterium Vibrio vulnificus. Cell Host Microbe. 2015, 17:47-57. 10.1016\/j.chom.2014.12.001","journal-title":"Cell Host Microbe"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-145-3-200608010-00008","article-title":"Screening for hemochromatosis: recommendation statement","volume":"145","year":"2006","unstructured":"Screening for hemochromatosis. recommendation statement. Ann Intern Med. 2006, 145:204-8. 10.7326\/0003-4819-145-3-200608010-00008","journal-title":"Ann Intern Med"},{"key":"ref30","unstructured":"U.S. Preventive Services Task Force. hemochromatosis: Screening (Inactive). (2025). Accessed: April 20, 2026: https:\/\/www.uspreventiveservicestaskforce.org\/uspstf\/recommendation\/hemochromatosis-screening."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/493933-hemochromatosis-associated-mortality-in-the-united-states-1999-2024-a-nationwide-joinpoint-analysis-of-trends-and-disparities","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T09:19:18Z","timestamp":1782638358000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/493933-hemochromatosis-associated-mortality-in-the-united-states-1999-2024-a-nationwide-joinpoint-analysis-of-trends-and-disparities"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,28]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.111643","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,28]]}}}